Is Alzheimer’s an infectious disease?

Alzheimer’s disease, the most common form of dementia, affects more than five million Americans, but the cause of it is still somewhat of a mystery. Now, a new theory has emerged—is the disease caused by bacteria, virus, fungus or a parasite?

That’s the question posed by Leslie Norins, PhD, a physician turned publisher, NPR reported. The theory has actually been around for a while but hasn’t gained much traction. Norins, however, believes the disease is characteristic of an infectious process, he told NPR, and hopes that some of the millions of dollars in funding that has been spent on Alzheimer’s disease research could explore this possibility.

Norins launched Alzheimer’s Germ Quest Inc. in 2017, a public benefit corporation that hopes to drive interest in the germ theory. The question of the cause of the disease could lead to new breakthroughs in treatment in the future.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.